Bayer becomes active member of HealthXL to foster evidence based digital health.
Bayer is expanding its global open innovation approach with HealthXL, and is supporting evidence based digital health startups. The partnership with HealthXL is one aspect of Bayer’s external engagement in the digital space:
“We see ourselves as an active partner in the global ecosystem of digital innovation, open for new ideas and creative approaches."
Eugene Borukhovich, Head of Digital Health at Bayer
For the past five years, Eugene Borukhovich has been an integral member of HealthXL and advisor to the community.
“There still continues to be a lot of noise in digital health and health technology. HealthXL is a good partner to move forward with to deliver upon our mission Science For A Better Life.”
Since 2012 Bayer supports Digital Health companies and passionate entrepreneurs through its #G4A programs which highlight the company’s commitment to collaboration with innovators and startups. Bayer recently launched its first US program focused on developing self-care innovation partnerships: G4A Generator.
“Bayer has been a leader in health technology for many years. We are delighted to expand our work with Eugene and the Bayer team as we progress our mutual objectives of identifying and bringing evidence based health technology into the global marketplace"
Martin Kelly, CEO HealthXL
Bayer will participate in HealthXL next Global Gathering, which is being hosted at the National Robotics Engineering Center part of Carnegie Mellon University in Pittsburgh, PA 8 February. Pittsburgh is one of the leading innovation and tech hubs in the US, the event will incorporate healthcare experts from UPMC, Philips and CMU and discuss topics such as Precision Medicine & Genomics and Big Data & AI - 'Hype v Reality'. More details here
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 99,600 people and had sales of EUR 34.9 billion. Capital expenditures amounted to EUR 2.2 billion, R&D expenses to EUR 4.4 billion. For more information, go to www.bayer.com
HealthXL builds global communities who want to improve health outcomes. Our platform connects innovators through evidence driven insights from world leading healthcare executives, clinicians and technologies. HealthXL works with 40+ leading global companies and health systems to provide insights, evidence and expertise on digital health and health technology.